Medivolve Financial Statements From 2010 to 2025
| MEDVF Stock | USD 0 0.00 0.00% |
Check Medivolve financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medivolve's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medivolve financial statements analysis is a perfect complement when working with Medivolve Valuation or Volatility modules.
Medivolve |
Medivolve Company Return On Asset Analysis
Medivolve's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medivolve Return On Asset | 0.0165 |
Most of Medivolve's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medivolve is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medivolve has a Return On Asset of 0.0165. This is 100.19% lower than that of the Healthcare sector and 100.22% lower than that of the Diagnostics & Research industry. The return on asset for all United States stocks is 111.79% lower than that of the firm.
Medivolve Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medivolve's current stock value. Our valuation model uses many indicators to compare Medivolve value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medivolve competition to find correlations between indicators driving Medivolve's intrinsic value. More Info.Medivolve is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medivolve's earnings, one of the primary drivers of an investment's value.About Medivolve Financial Statements
Medivolve stakeholders use historical fundamental indicators, such as Medivolve's revenue or net income, to determine how well the company is positioned to perform in the future. Although Medivolve investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medivolve's assets and liabilities are reflected in the revenues and expenses on Medivolve's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medivolve. Please read more on our technical analysis and fundamental analysis pages.
It is a social-impact investment focused company Investing resources, funds and bandwidth for the betterment of the human condition through medical sciences, climate change and technology. Copper One Inc. was incorporated in 2005 and is headquartered in Toronto, Canada. Medivolve operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 210 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Medivolve Pink Sheet
Medivolve financial ratios help investors to determine whether Medivolve Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medivolve with respect to the benefits of owning Medivolve security.